AMR Alliance Japan (Secretariat: Health and Global Policy Institute) held a meeting to discuss its FY2025 plans among Alliance members.

AMR Alliance Japan, as an independent platform for multisector discussion with the mission of contributing to the improvement of public health by promoting measures on AMR, will continue to work with Alliance members and partner organizations to deepen policy debate around AMR.

[Overview]

• Date & Time: Tuesday, May 13, 2025
• Format: Online (Zoom meeting)
• Organizer: AMR Alliance Japan (Secretariat: HGPI)

■ Discussion

Participants (Titles omitted; in gojūon syllabary order)

Tetsuo Asai (Chariman, Japanese Society of Antimicrobials for Animals/ Professor, Joint Graduate School of Veterinary Sciences, Gifu University)
Kyoko Ama (Representative, Children and Healthcare Project/ Fellow, Health and Global Policy Institute)
Yusuke Ariyoshi (New Product Planning Department, Shionogi Pharmaceutical Co., Ltd.)
Takahito Ikeda (Senior Staff, Community Medical Division, Health and Welfare Bureau, Himeji City)
Kae Ikeda (Chief, One Health General Promotion Division, Department of Public Health and Medical Affairs, Fukuoka Prefectural Government)
Yoko Kayama (Japan Medicine Development Leader, Japan Development, GlaxoSmithKline K.K.)
Michiyo Kawana (Managing Director, Japan Pharmaceutical Association)
Takashi Kitahara (Board Member, Japanese Society of Hospital Pharmacists)
Hideaki Sakamoto (Incentive Task Force Leader, Japan Pharmaceutical Manufacturers Association)
Hayato Shishido (Department Head of Marketing Department, Shimadzu Diagnostics Corporation)
Satoshi Takahashi (Chairperson of the Board of Directors, Japanese Society of Chemotherapy)
Yoshisaburo Takahashi (Corporate Planning & Strategy, Meiji Seika Pharma Co., Ltd.)
Hidemasa Nakaminami (Professor, Tokyo University of Pharmacy and Life Scienses/ The Pharmaceutical Society of Japan)
Tsubasa Hamada (Public & External Affairs Dept., Meiji Seika Pharma Co., Ltd.)
Junichi Hirayama (Medical Affairs, bioMérieux Japan Ltd.)
Runa Masuda (Clerk, Community Medical Division, Health and Welfare Bureau, Himeji City)
Akinobu Matsuda (Manager, Community Medical Division, Health and Welfare Bureau, Himeji City)
Junji Miyaji (Marketing Director, DS, BD Japan)
Yuichi Muraki (Director, Japanese Society of Pharmaceutical Health Care and Sciences)
Takeo Morooka (Merck ＆Co., Inc./ Representative Director, PH Consulting LLC)
Akira Yuasa (Director, HEOR Lead, Access & Value, Pfizer Japan Inc.)
Kazuhiko Yoshikawa (Director, Public & External Affairs Dept., Meiji Seika Pharma Co., Ltd.)
Yoshinori Watanabe (Shimadzu Diagnostics Corporation)